Skip to Content

RDY 454 (Venlafaxine Hydrochloride Extended Release 75 mg)

Pill with imprint RDY 454 is Pink, Capsule-shape and has been identified as Venlafaxine Hydrochloride Extended Release 75 mg. It is supplied by Dr. Reddy's Laboratories Ltd..

Venlafaxine is used in the treatment of anxiety; autism; major depressive disorder; generalized anxiety disorder; depression and belongs to the drug class serotonin-norepinephrine reuptake inhibitors. Risk cannot be ruled out during pregnancy. Venlafaxine 75 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for RDY 454

Venlafaxine Hydrochloride Extended Release

Imprint
RDY 454
Strength
75 mg
Color
Pink
Size
19.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Serotonin-norepinephrine reuptake inhibitors
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Dr. Reddy's Laboratories Ltd.
National Drug Code (NDC)
55111-0454
Inactive Ingredients
dimethylaminoethyl methacrylate - butyl methacrylate - methyl methacrylate copolymer, ethylcelluloses, gelatin, medium-chain triglycerides, microcrystalline cellulose, povidone, ferric oxide red, sodium stearyl fumarate, magnesium silicate, titanium dioxide, ferrosoferric oxide, potassium hydroxide, propylene glycol, shellac, ammonia

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.